PriceScrib / Switzerland
BAG snapshot · 3 November 2026 · CHFPriceScrib. Swiss medicine list prices.
Limited preview: 30 published packs across ten Swiss authorisation holders, selected from the largest SL portfolios by listed pack count. Sample results are not representative of the full market or sales share.
Sample packs
30
Products
17
Companies
10
Sample median price
CHF 191.05
Product-level prices
| Product / active ingredient | Form & pack | Authorisation holder | Public CHF incl. VAT | Last factory-price change |
|---|---|---|---|---|
Abacavir Lamivudin Sandoz Abacavirum, Lamivudinum J05AR02 | Filmtabl 600/300mg Blist 30 Stk | Sandoz Pharmaceuticals AG | CHF 268.95 | 2025-12-01 |
Abirateron Accord Abirateroni acetas L02BX03 · Reimbursement limitation · Price model | Filmtabl 500 mg Blist 56 Stk | Accord Healthcare AG | CHF 992.05 | 2022-04-01 |
Abirateron Sandoz Abirateroni acetas L02BX03 · Reimbursement limitation · Price model | Filmtabl 1000 mg Blist 28 Stk | Sandoz Pharmaceuticals AG | CHF 992.85 | 2022-10-01 |
Abirateron Sandoz Abirateroni acetas L02BX03 · Reimbursement limitation · Price model | Filmtabl 500 mg Blist 56 Stk | Sandoz Pharmaceuticals AG | CHF 992.05 | 2022-01-01 |
Abirateron Spirig HC Abirateroni acetas L02BX03 · Reimbursement limitation · Price model | Filmtabl 500 mg Blist 56 Stk | Spirig HealthCare AG | CHF 992.05 | 2022-01-01 |
Showing 5 of 30 matching sample packs.
Your pricing analytics dashboard
Click here to request your plug-and-play pricing analytics dashboardSource & interpretation
Official Federal Office of Public Health (BAG/OFSP) Specialities List, published 3 November 2026. This is a fixed snapshot, not live pricing; no price-history trend is inferred. Prices are per specified pack, not per dose or treatment. Products, strengths and pack sizes may not be comparable. Actual net prices, rebates, reimbursement conditions and patient costs can differ.
Only SL entries are included; GGSL and GGML entries are excluded. “Company” means the Swiss authorisation holder as published, not a consolidated global group. Missing prices are excluded from medians. This is market information, not medical or prescribing advice.